Diaminopyrimidines as P2X3 and P2X2/3 modulators
US7531547B2 · kind B2 · utility
31Cited by
42References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2006 |
| Grant date | May 12, 2009 |
| Priority date | — |
| Expiry date | Aug 25, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I):wherein D, X, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.